Tourmaline Bio, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €16.24M
    R&D expenses
    €93.42M
    EBITDA
    -€106.60M
    D&A
    -€8.46M
    EBIT
    -€100.68M
    Interest expenses
    -€3.17M
    EBT
    -€82.02M
    Tax expenses
    -€2.62M
    Net income
    -€83.38M

    Cash flow statement

    Net deferred tax
    €13.17M
    Non-cash items
    -€29.90M
    Changes in working capital
    €2.43M
    Operating cash flow
    -€89.65M
    Capex
    -€444.56K
    Other investing cash flow
    -€31.77K
    Net investing cash flow
    -€172.38M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €139.01M
    Debt repayment
    €0.00
    Other financing cash flow
    €374.77K
    Net financing cash flow
    €139.38M
    Foreign exchange effects
    €7.85M
    Net change in cash
    €3.23M
    Cash at end of period
    €27.27M
    Free cash flow
    -€90.09M

    Balance sheet

    Cash and cash equivalents
    €27.07M
    Cash and short-term investments
    €206.11M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €8.50M
    Total current assets
    €214.61M
    Property, plant & equipment
    €149.91K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €14.80M
    Other non-current assets
    €2.44M
    Total non-current assets
    €17.40M
    Total assets
    €232.01M
    Accounts payable
    €2.73M
    Short-term debt
    €124.92K
    Other current liabilities
    €5.84M
    Total current liabilities
    €8.70M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €6.89K
    Total non-current liabilities
    €6.89K
    Total liabilities
    €8.70M
    Common stock
    €2.58K
    Retained earnings
    -€156.22M
    Other equity
    €104.25K
    Total equity
    €223.31M
    Total liabilities and shareholders' equity
    €232.01M

    Company information

    Market capitalization
    €362.41M
    Employees
    74
    Enterprise Value
    €455.39M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -37.3%
    ROA
    -35.9%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -24.6%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.13M

    Notifications